Philippe Bourget

3.8k citations

91 papers · 1.8k indexed · h-index 24

Impact in

Occupational Therapy top 2%
- Safe Handling of Antineoplastic Drugs
Pediatrics, Perinatology and Child Health top 5%

Papers in ⓘ

Occupational Therapy 8
- Safe Handling of Antineoplastic Drugs 8
Medical Laboratory Technology 2

Co-authors: H. Fernandez (16 shared papers)Angélo Paci (19 shared papers)Fabrice Vidal (12 shared papers)R Frydman (4 shared papers)D. Élias (2 shared papers)Michel Ducreux (2 shared papers)C. Lelaidier (4 shared papers)Cindy Neuzillet (6 shared papers)
Journals: Journal of Pharmaceutical and Biomedical Analysis (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)International Journal of Pharmaceutics (4 papers)Blood (2 papers)Annals of Oncology (2 papers)
Partner nations: France United States Tunisia

In The Last Decade

Philippe Bourget

89 papers receiving 1.7k citations

Peers

Countries citing papers authored by Philippe Bourget

Since Specialization

Citations

This map shows the geographic impact of Philippe Bourget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Bourget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Bourget more than expected).

Fields of papers citing papers by Philippe Bourget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Bourget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Bourget. The network helps show where Philippe Bourget may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Bourget, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Bourget Line = papers co-authored together Philippe Bourget links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial The Lancet Neurology ·Marc Tardieu, Michel Zérah, Marie‐Lise Gougeon, Jérôme Ausseil, Stéphanie de Bournonville, B. Husson, Dimitrios Zafeiriou, Giancarlo Parenti, Philippe Bourget, Béatrice Poirier, Valérie Furlan, Cécile Artaud, Thomas Baugnon, Thomas Roujeau, Ronald G. Crystal, Christian Meyer, Kumaran Deiva, Jean‐Michel Heard	2017	151
2	Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β ^A(T87Q) - Globin Gene Human Gene Therapy ·Olivier Nègre, Anne-Virginie Eggimann, Yves Beuzard, Jean‐Antoine Ribeil, Philippe Bourget, Suparerk Borwornpinyo, Suradej Hongeng, Salima Hacein‐Bey, Marina Cavazzana, Philippe Leboulch, Emmanuel Payen	2016	121
3	Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance Annals of Oncology ·D. Élias, Tadashi Matsuhisa, Lucas Sidéris, Gabriel Liberale, L. Drouard-Troalen, Bruno Raynard, Marc Pocard, J.M. Puizillou, V. Billard, Philippe Bourget, Michel Ducreux	2004	106
4	State of the art and future directions of pancreatic ductal adenocarcinoma therapy Pharmacology & Therapeutics ·Cindy Neuzillet, Annemilaï Tijeras‐Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie‐Pierre Vullierme, Christophe Tournigand, Pascal Hammel	2015	82
5	Human Pharmacokinetic Study of Heated Intraperitoneal Oxaliplatin in Increasingly Hypotonic Solutions after Complete Resection of Peritoneal Carcinomatosis Oncology ·D. Élias, A. El Otmany, M. Bonnay, Angélo Paci, Michel Ducreux, S. Antoun, P Lasser, S. Laurent, Philippe Bourget	2002	73
6	Is the Reduced Efficacy of Morphine in Diabetic Rats Caused by Alterations of Opiate Receptors or of Morphine Pharmacokinetics? Journal of Pharmacology and Experimental Therapeutics ·Christine Courteix, Philippe Bourget, F. Caussade, M. Bardin, François Coudoré, J. Fialip, Alain Eschalier	1998	65
7	Models for Placental Transfer Studies of Drugs Clinical Pharmacokinetics ·Philippe Bourget, Cédric Roulot, H. Fernandez	1995	63
8	Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children Biology of Blood and Marrow Transplantation ·Bénédicte Neven, Jean‐Sébastien Diana, Martin Castelle, Alessandra Magnani, Jérémie Rosain, Fabien Touzot, Baptiste Moreira, Marie‐Louise Frémond, Coralie Briand, Matthieu Bendavid, Romain Lévy, Guillaume Morelle, Marc Vincent, Elsa Magrin, Philippe Bourget, Lucienne Chatenoud, Capucine Pïcard, Alain Fischer, Despina Moshous, Stéphane Blanche	2019	57
9	Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analysis of local versus intramuscular administration Fertility and Sterility ·H. Fernandez, Philippe Bourget, Y. Ville, C. Lelaidier, R Frydman	1994	51
10	In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model Antimicrobial Agents and Chemotherapy ·Pierre Moine, E Vallée, E. Azoulay-Dupuis, Philippe Bourget, J.P. Bédos, J Bauchet, J J Pocidalo	1994	49
11	The place of methotrexate in the management of interstitial pregnancy Human Reproduction ·H. Fernandez, Dominique de Ziegler, Philippe Bourget, Pierre Feltain, R Frydman	1991	48
12	Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection Antimicrobial Agents and Chemotherapy ·Philippe Bourget, A. Lesne-Hulin, R. Le Reveille, H. Le Bever, H. Carsin	1996	47
13	Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. PubMed ·Vincent Launay‐Vacher, Hassane Izzedine, Jean‐Baptiste Rey, Olivier Rixe, Sophie Chapalain, Souraya Nourdine, Angélo Paci, Philippe Bourget, Gilbert Deray	2004	41
14	Comparison of Raman spectroscopy vs. high performance liquid chromatography for quality control of complex therapeutic objects: Model of elastomeric portable pumps filled with a fluorouracil solution Journal of Pharmaceutical and Biomedical Analysis ·Philippe Bourget, Alexandre Amin, Fabrice Vidal, Christophe Merlette, Frédéric Lagarce	2014	34
15	Identification and quantitation of antineoplastic compounds in chemotherapeutic infusion bags by use of HPTLC: application to the vinca-alkaloids Journal of Pharmaceutical and Biomedical Analysis ·Angélo Paci, Lionel Mercier, Philippe Bourget	2002	33
16	Routine application of Raman spectroscopy in the quality control of hospital compounded ganciclovir International Journal of Pharmaceutics ·Alexandre Amin, Philippe Bourget, Fabrice Vidal, Flavie Ader	2014	32
17	Pharmacokinetics and protein binding of ceftriaxone during pregnancy Antimicrobial Agents and Chemotherapy ·Philippe Bourget, H. Fernandez, V Quinquis, C Delouis	1993	31
18	Near infrared spectroscopy and process analytical technology to master the process of busulfan paediatric capsules in a university hospital Journal of Pharmaceutical and Biomedical Analysis ·Ian Paris, A. Janoly-Duménil, Angélo Paci, Lionel Mercier, Philippe Bourget, Françoise Brion, Pierre Chaminade, André Rieutord	2006	28
19	Fluorescence detection combined with either HPLC or HPTLC for pharmaceutical quality control in a hospital chemotherapy production unit: Application to camptothecin derivatives Journal of Pharmaceutical and Biomedical Analysis ·Edmond Gravel, Philippe Bourget, Lionel Mercier, Angélo Paci	2005	27
20	Flecainide Distribution, Transplacental Passage, and Accumulation in the Amniotic Fluid during the Third Trimester of Pregnancy Annals of Pharmacotherapy ·Philippe Bourget, Jean‐Claude Pons, C Delouis, L Fermont, René Frydman	1994	25

About Philippe Bourget

Philippe Bourget is a scholar working on Occupational Therapy, Medical Laboratory Technology, Pharmacology, Anesthesiology and Pain Medicine and Molecular Medicine, having authored 91 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pharmaceutical studies and practices (8 papers), Safe Handling of Antineoplastic Drugs (8 papers), Ectopic Pregnancy Diagnosis and Management (6 papers), Pregnancy and Medication Impact (6 papers), Anesthesia and Pain Management (6 papers), Gestational Trophoblastic Disease Studies (5 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (4 papers). The work is most often cited by research in Occupational Therapy (106 citations), Pediatrics, Perinatology and Child Health (347 citations), Emergency Medicine (156 citations), Biophysics (88 citations) and Applied Microbiology and Biotechnology (30 citations). Philippe Bourget has collaborated with scholars based in France, United States and Tunisia. Frequent co-authors include H. Fernandez, Angélo Paci, Fabrice Vidal, R Frydman, D. Élias, Michel Ducreux, C. Lelaidier, Cindy Neuzillet, H. Carsin and Christophe Tournigand. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics, Blood and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact